174 related articles for article (PubMed ID: 33724633)
1. Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients.
Wang R; Han JH; Lautenbach E; Tamma PD; Thom KA; Alby K; Blumberg EA; Bilker WB; Werzen A; Omorogbe J; Tolomeo P; Anesi JA
Transpl Infect Dis; 2021 Aug; 23(4):e13599. PubMed ID: 33724633
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Extended-Spectrum β-lactamase-Producing Enterobacterales Bloodstream Infection Among Solid-Organ Transplant Recipients.
Anesi JA; Lautenbach E; Tamma PD; Thom KA; Blumberg EA; Alby K; Bilker WB; Werzen A; Tolomeo P; Omorogbe J; Pineles L; Han JH
Clin Infect Dis; 2021 Mar; 72(6):953-960. PubMed ID: 32149327
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ;
Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189
[TBL] [Abstract][Full Text] [Related]
5. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM;
Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
Anesi JA; Lautenbach E; Thom KA; Tamma PD; Blumberg EA; Alby K; Bilker WB; Werzen A; Ammazzalorso A; Tolomeo P; Omorogbe J; Pineles L; Han JH
Transplantation; 2023 Jan; 107(1):254-263. PubMed ID: 35856636
[TBL] [Abstract][Full Text] [Related]
8. Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing
Gutiérrez-Gutiérrez B; Pérez-Nadales E; Pérez-Galera S; Fernández-Ruiz M; Carratalà J; Oriol I; Cordero E; Lepe JA; Tan BH; Corbella L; Paul M; Natera AM; David MD; Montejo M; Iyer RN; Pierrotti LC; Merino E; Steinke SM; Rana MM; Muñoz P; Mularoni A; van Delden C; Grossi PA; Seminari EM; Gunseren F; Lease ED; Roilides E; Fortún J; Arslan H; Coussement J; Tufan ZK; Pilmis B; Rizzi M; Loeches B; Eriksson BM; Abdala E; Soldani F; Lowman W; Clemente WT; Bodro M; Fariñas MC; Kazak E; Martínez-Martínez L; Aguado JM; Torre-Cisneros J; Pascual Á; Rodríguez-Baño J;
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0110221. PubMed ID: 34370578
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
10. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
[TBL] [Abstract][Full Text] [Related]
11. Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study.
Ling W; Paterson DL; Harris PNA; Furuya-Kanamori L; Edwards F; Laupland KB
Int J Infect Dis; 2024 Jan; 138():84-90. PubMed ID: 37949363
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).
Gudiol C; Royo-Cebrecos C; Tebe C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Carratalà J;
BMJ Open; 2017 Jan; 7(1):e013268. PubMed ID: 28115333
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
Winters HA; Parbhoo RK; Schafer JJ; Goff DA
Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
[TBL] [Abstract][Full Text] [Related]
14. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
[TBL] [Abstract][Full Text] [Related]
15. Colonization by Extended-Spectrum β-Lactamase-Producing Enterobacterales and Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Gonçalves LA; Anjos BB; Tavares BM; Marchi AP; Côrtes MF; Higashino HR; de Carvalho Moraes BDG; Bampi JVB; Pinheiro LD; Spadao FS; Rocha V; Guimarães T; Costa SF
Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786176
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Palacios-Baena ZR; Gutiérrez-Gutiérrez B; De Cueto M; Viale P; Venditti M; Hernández-Torres A; Oliver A; Martínez-Martínez L; Calbo E; Pintado V; Gasch O; Almirante B; Antonio Lepe J; Pitout J; Akova M; Peña-Miralles C; Schwaber MJ; Tumbarello M; Tacconelli E; Origüen J; Prim N; Bou G; Giamarellou H; Bermejo J; Hamprecht A; Pérez F; Almela M; Lowman W; Hsueh PR; Navarro-San Francisco C; Torre-Cisneros J; Carmeli Y; Bonomo RA; Paterson DL; Pascual Á; Rodríguez-Baño J;
J Antimicrob Chemother; 2017 Mar; 72(3):906-913. PubMed ID: 28062685
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Extended-Spectrum-β-Lactamase-Producing
Baek YJ; Kim YA; Kim D; Shin JH; Uh Y; Shin KS; Shin JH; Jeong SH; Lee GW; Lee EJ; Kim DS; Park YS
Ann Lab Med; 2021 Sep; 41(5):455-462. PubMed ID: 33824233
[TBL] [Abstract][Full Text] [Related]
18. Can the pan-immune-inflammation value predict gram negative bloodstream infection-related 30-day mortality in solid organ transplant patients?
Ayaz ÇM; Turhan Ö; Yılmaz VT; Adanır H; Sezer B; Öğünç D
BMC Infect Dis; 2024 May; 24(1):526. PubMed ID: 38789916
[TBL] [Abstract][Full Text] [Related]
19. Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016.
Vock I; Aguilar-Bultet L; Egli A; Tamma PD; Tschudin-Sutter S
Euro Surveill; 2020 Jul; 25(26):. PubMed ID: 32643598
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
